Cargando…

MRI with ferumoxytol: A single center experience of safety across the age spectrum

PURPOSE: To summarize our single‐center safety experience with the off‐label use of ferumoxytol for magnetic resonance imaging (MRI) and to compare the effects of ferumoxytol on monitored physiologic indices in patients under anesthesia with those of gadofosveset trisodium. MATERIALS AND METHODS: Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Kim‐Lien, Yoshida, Takegawa, Han, Fei, Ayad, Ihab, Reemtsen, Brian L., Salusky, Isidro B., Satou, Gary M., Hu, Peng, Finn, J. Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290274/ https://www.ncbi.nlm.nih.gov/pubmed/27480885 http://dx.doi.org/10.1002/jmri.25412

Ejemplares similares

Ferumoxytol across the age spectrum: a single center experience of safety
por: Nguyen, Kim-Lien, et al.
Publicado: (2016)

4D Multiphase steady state imaging with contrast (MUSIC) enhancement using ferumoxytol: a new paradigm in pediatric congenital heart disease
por: Nguyen, Kim-Lien, et al.
Publicado: (2016)

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging
por: Nguyen, Kim-Lien, et al.
Publicado: (2017)

Ferumoxytol-enhanced 4D multiphase, steady-state imaging with magnetic resonance in congenital heart disease: ventricular volume and function across 2D and 3D software platforms
por: Yoshida, Takegawa, et al.
Publicado: (2022)

Ferumoxytole-enhanced 4D MR angiography with retrospectively defined temporal resolution
por: Zhou, Ziwu, et al.
Publicado: (2016)

Ferumoxytol MR angiography for pre-TAVR assessment
por: Finn, J Paul, et al.
Publicado: (2016)

Ferumoxytol MRA and non-contrast CT fusion in TAVR candidates with renal failure
por: Yoshida, Takegawa, et al.
Publicado: (2016)

4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease
por: Nguyen, Kim-Lien, et al.
Publicado: (2017)

Contemporary sequential segmental approach to congenital heart disease using four-dimensional magnetic resonance imaging with ferumoxytol: an illustrated editorial
por: Yoo, Shi-Joon, et al.
Publicado: (2023)

High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion
por: Shahrouki, Puja, et al.
Publicado: (2019)

High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol
por: Shahrouki, Puja, et al.
Publicado: (2021)

Ferumoxytol-Enhanced Cardiac Magnetic Resonance Angiography and 4D Flow: Safety and Utility in Pediatric and Adult Congenital Heart Disease
por: Renella, Pierangelo, et al.
Publicado: (2022)

Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019)

4-dimensional, multiphase, steady-state imaging with contrast enhancement (MUSIC) in the heart; a feasibility study in children
por: Han, Fei, et al.
Publicado: (2015)

The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions
por: Chalouhi, Nohra, et al.
Publicado: (2013)

Vascular mapping of the human hippocampus using Ferumoxytol-enhanced MRI
por: Buch, Sagar, et al.
Publicado: (2022)

Steady-state ferumoxytol-enhanced MRI: early observations in benign abdominal organ masses and clinical implications
por: Shahrouki, Puja, et al.
Publicado: (2021)

CMR in pediatric patients with congenital heart disease: comparison at 1.5T and at 3.0T
por: Nguyen, Kim-Lien, et al.
Publicado: (2012)

Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)

Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations
por: Plock, Nele, et al.
Publicado: (2014)

Self-Assembling Nanocomplexes by combining Ferumoxytol, Heparin And Protamine For Cell Tracking by MRI
por: Thu, Mya S., et al.
Publicado: (2012)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017)

Cost benefits of cardiovascular magnetic resonance imaging and angiography performed earlier in the diagnostic assessment of neonatal complex congenital heart disease
por: Renella, Pierangelo, et al.
Publicado: (2014)

High-field MR imaging in pediatric congenital heart disease: Initial results
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains
por: Theruvath, Ashok Joseph, et al.
Publicado: (2020)

Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI
por: Muehe, Anne Monika, et al.
Publicado: (2020)

Safety and efficacy of a single total dose infusion (1020 mg) of ferumoxytol
por: Khan, Harris, et al.
Publicado: (2021)

Cardiac and respiratory self-gated 4D multi-phase steady-state imaging with ferumoxytol contrast (MUSIC)
por: Han, Fei, et al.
Publicado: (2016)

A New Method for Preparing Mesenchymal Stem Cells and Labeling with Ferumoxytol for Cell Tracking by MRI
por: Liu, Li, et al.
Publicado: (2016)

Macrophage phagocytosis alters the MRI signal of ferumoxytol-labeled mesenchymal stromal cells in cartilage defects
por: Nejadnik, Hossein, et al.
Publicado: (2016)

The ferumoxytol in renal insufficiency study (FiRST)
por: Vemulapalli, Sreekanth, et al.
Publicado: (2013)

Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent
por: Hedgire, Sandeep S, et al.
Publicado: (2014)

Improved 2D slice-interleaved flow-independent cardiac black blood imaging using Ferumoxytol
por: Lu, Junfei, et al.
Publicado: (2015)

Acute effects of ferumoxytol on regulation of renal hemodynamics and oxygenation
por: Cantow, Kathleen, et al.
Publicado: (2016)

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Extracellular magnetic labeling of biomimetic hydrogel-induced human mesenchymal stem cell spheroids with ferumoxytol for MRI tracking
por: Yan, Sen, et al.
Publicado: (2022)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
por: Adkinson, N. Franklin, et al.
Publicado: (2018)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
por: Ford, David C, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ngia3dg5d5ntdoomdftf9275ca